Pharma Tubing Market to Hit US$23.8 Billion by 2031 Amid Surge in Biologics and Injectable Drug Production| TMR Research

The global pharma tubing market, valued at US$15.0 billion in 2022, is poised for steady growth. It is estimated to advance at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2031, reaching US$23.8 billion by 2031. This expansion reflects rising demand for high-quality tubing in pharmaceutical manufacturing and drug delivery systems, driven by healthcare advancements and regulatory standards. With a projected increase of nearly 59%, pharma tubing is set to enhance pharmaceutical processes through 2031.

To Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85502

Understanding the Pharma Tubing Market

Pharma tubing, made from materials like silicone, PVC, and thermoplastic elastomers (TPE), is used for fluid transfer, drug delivery, and bioprocessing in pharmaceutical production. These tubes ensure sterility, chemical resistance, and compliance with USP Class VI and FDA standards, critical for 30% of pharmaceutical applications, per 2023 industry reports. The 2022 valuation of US$15.0 billion underscores its vital role, with the projected rise to US$23.8 billion by 2031 driven by the silicone tubing segment, which held a 40% share in 2022 due to its flexibility and biocompatibility. The 5.3% CAGR reflects its ability to support 20% of biopharmaceutical production needs, per TMR.

Key Drivers of Market Growth

Several factors are propelling the pharma tubing market toward its US$23.8 billion milestone by 2031. First, the growth of the pharmaceutical industry is a primary driver. Global pharmaceutical spending, reaching US$1.5 trillion in 2023, per IQVIA, fuels demand for tubing in drug manufacturing and packaging, with 25% of production lines using specialized tubing. North America, holding a 35% market share in 2022, leads due to U.S. biopharma investments, supporting applications like peristaltic pumps and IV delivery systems.

Second, technological advancements in tubing materials drive growth. Innovations in low-leachability TPE tubing, like Saint-Gobain's 2023 C-Flex formulations, reduce contamination risks by 15%, per Pharmaceutical Technology Journal. These advancements, adopted by 10% of manufacturers, support the 5.3% CAGR, with single-use systems growing at 5.6% CAGR for their cost-efficiency in 20% of bioprocessing applications. Companies like DuPont and Freudenberg Medical are scaling production, with DuPont's 2023 facility increasing output by 30%, per TMR.

Third, stringent regulatory requirements and sustainability trends enhance adoption. Regulations like EU GMP Annex 1 and U.S. FDA cGMP mandate high-purity tubing, driving demand in 15% of sterile applications. Sustainability initiatives, with 20% of pharma companies like Pfizer adopting eco-friendly materials per 2023 CDP reports, boost TPE and bio-based tubing. Consumer awareness, with 60% favoring sustainable healthcare products per a 2023 Nielsen survey, and e-commerce, handling 10% of tubing sales, reinforce the market's trajectory to US$23.8 billion.

Leading Companies:

DuPont.
Saint-Gobain
BIT-SERV GmbH
Avient Corporation
Freudenberg Medical
Kent Elastomer
DWK Life Sciences
Jehbco Manufacturing Pty Ltd
FLUOROTHERM
Silex Ltd
Ami Polymer
Adtech Polymer Engineering Ltd.

To Know more About Report - https://www.transparencymarketresearch.com/pharma-tubing-market.html

Market Segmentation and Regional Insights

The market segments by material, application, and end-use. Silicone tubing led in 2022 with a 40% share, valued for durability, while TPE tubing grows at 5.8% CAGR for its recyclability, per TMR. Fluid transfer applications dominate with a 50% share, driven by bioprocessing, followed by drug delivery and packaging. End-uses include biopharmaceuticals (60%), pharmaceuticals, and research, with biopharmaceuticals leading due to single-use system adoption.

Regionally, North America led in 2022 with a 35% share, valued at US$5.25 billion, driven by U.S. and Canada's advanced pharma infrastructure, projecting a 5.2% CAGR. Europe held a 30% share, fueled by Germany and Switzerland's biopharma hubs, growing at 5.4% CAGR. Asia-Pacific, with a 25% share, grows at 5.7% CAGR, driven by China and India's expanding generics market, while Latin America and Africa lag due to regulatory gaps, per TMR.

Challenges and Opportunities

The market faces challenges. High production costs, 10-15% above standard tubing, and raw material price volatility, affecting 5% of silicone supply, pose risks. Competition from biopharmaceutical tubing, valued at US$3.4 billion in 2023, and limited adoption in 10% of developing markets hinder growth. The 5.3% CAGR reflects a market navigating these hurdles with strong healthcare demand.

These challenges present opportunities. Advances in bio-based TPE, like Teknor Apex's 2023 formulations, could reduce costs by 10%. Emerging markets in Africa, growing at 6.0% CAGR, and partnerships, like Nordson's 2023 tubing collaborations, enhance scalability. Regulatory incentives, covering 5% of R&D, support the push to US$23.8 billion.

The Road to 2031

By 2031, the global pharma tubing market is projected to reach US$23.8 billion, reflecting nine years of steady growth at a 5.3% CAGR from US$15.0 billion in 2022. This milestone is driven by pharmaceutical growth, technological advancements, and sustainability trends. The market's trajectory suggests continued expansion, advancing drug manufacturing and delivery.

In conclusion, the global pharma tubing market demonstrates robust growth from 2023 to 2031. Rising from US$15.0 billion to US$23.8 billion, it addresses quality and sustainability needs with advanced tubing. Stakeholders-from producers like Saint-Gobain, DuPont, and Freudenberg Medical to pharma companies and researchers-play a vital role, ensuring pharma tubing shapes a safer, greener future through 2031 and beyond.

Explore Latest Research Reports by Transparency Market Research:

Methanol-to-Olefins Market: https://www.globenewswire.com/news-release/2025/02/28/3034749/32656/en/Methanol-to-Olefins-Market-Size-to-Reach-USD-44-1-Billion-by-2034-at-5-5-CAGR-Driven-by-Sustainability-and-Abundant-Methanol-Supply-Analysis-by-TMR.html

Caproic Acid Market: https://www.globenewswire.com/news-release/2025/01/24/3014877/32656/en/Caproic-Acid-Market-Set-for-Steady-Growth-Projected-to-Reach-106-4-Million-by-2034-TMR-Analysis.html

Recombinant Chemicals Market : https://www.globenewswire.com/news-release/2025/01/31/3018829/32656/en/Recombinant-Chemicals-Market-to-Reach-US-6-7-Bn-by-2034-Driven-by-Rising-Demand-for-Protein-Based-Vaccines-Genetic-Disorder-Treatments-TMR-Analysis.html

Baby Skincare Market: https://www.globenewswire.com/news-release/2025/01/20/3012178/32656/en/Baby-Skincare-Market-Set-to-Grow-6-1-Annually-Driven-by-Surging-Demand-for-Organic-and-Chemical-Free-Products-by-2034-Latest-Insights-by-TMR.html

AI-powered Chemical Manufacturing Market: https://www.globenewswire.com/news-release/2025/03/20/3046145/32656/en/AI-powered-Chemical-Manufacturing-Market-to-Expand-at-28-8-CAGR-Generating-US-37-6-Billion-by-2034-as-Industry-Embraces-Smart-Technologies-Latest-Report-by-Transparency-Market-Rese.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

This release was published on openPR.